OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
Ying Huang, Nima S. Hejazi, Bryan S. Blette, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2029-2029
Open Access | Times Cited: 11
Ying Huang, Nima S. Hejazi, Bryan S. Blette, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2029-2029
Open Access | Times Cited: 11
Showing 11 citing articles:
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial
Peter B. Gilbert, Youyi Fong, Nima S. Hejazi, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2181-2190
Closed Access | Times Cited: 6
Peter B. Gilbert, Youyi Fong, Nima S. Hejazi, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2181-2190
Closed Access | Times Cited: 6
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Bo Zhang, Youyi Fong, Lauren Dang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Bo Zhang, Youyi Fong, Lauren Dang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
Amparo L. Figueroa, Kashif Ali, Gary Berman, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Amparo L. Figueroa, Kashif Ali, Gary Berman, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations
Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Bo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
Lindsay N. Carpp, Ollivier Hyrien, Youyi Fong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Lindsay N. Carpp, Ollivier Hyrien, Youyi Fong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Long-term safety and efficacy of COVE study open-label and booster phases
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, et al.
Research Square (Research Square) (2024)
Open Access
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, et al.
Research Square (Research Square) (2024)
Open Access
Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity
Sjoerd Viktor Beentjes, J. Kaczmarczyk, A. Cassar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sjoerd Viktor Beentjes, J. Kaczmarczyk, A. Cassar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
